FDA Panel Unclear on Osteoporosis Drug Labels

Filed under: Health,News |


Labels on bisphosphonates, a type of medication used to treat and prevent osteoporosis, should further clarify how long patients can take them, an FDA advisory panel voted today.

Read more:

FDA Panel Unclear on Osteoporosis Drug Labels

Related Posts Plugin for WordPress, Blogger...
Posted by on September 10, 2011. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply